CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), ...

Australian medicines regulator, the Therapeutic Goods Administration (TGA), has granted approval for mRESVIA (mRNA-1345), an ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

Contracting a non-COVID lower respiratory tract infection raises the risk of death 2 to 7 times over the next month to a year ...

In recent years, the familiar symptoms of the flu might kick us into reaching for at-home testing kits. But on the eve of the ...

Largest childhood preventative health initiative in nearly 20 yearsBeyfortus rollout to ensure all babies are RSV protected this winterThe largest ...

The Royal Australian College of GPs (RACGP) has thrown its support behind Victoria's infant RSV vaccine program.Respiratory syncytial virus, or RSV ...

Measles cases are surging in Texas. Dr. Kevin Davis explains symptoms, risks, and how vaccination can help protect families from the outbreak.

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

The New York State Department of Agriculture and Markets on March 28 warned consumers about the risk of H5N1 avian flu from ...